Clinical Trial Update: Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control [Phase 2]

View source ↗

Summary

Phase II clinical trial update for ART plus dual broadly neutralizing antibodies versus ART plus placebo in primary HIV-1 infection, assessing the impact on pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Broadly neutralizing antibodies (bNAbs) - dual (dual broadly neutralizing antibodies)
• antiretroviral therapy (ART) (antiretroviral therapy)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV/AIDS and Infections | Phase 2 | Status: RECRUITING